ABBV logo

AbbVie (ABBV) Working Capital

Annual Working Capital

-$4.84 B
-$3.76 B-350.14%

31 December 2023

ABBV Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

-$15.28 B
-$7.18 B-88.63%

30 September 2024

ABBV Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABBV Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-350.1%-886.3%
3 y3 years-7.8%-3703.1%
5 y5 years-1545.9%-671.5%

ABBV Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-350.1%+33.4%-3703.1%at low
5 y5 years-114.3%+33.4%-143.3%at low
alltimeall time-114.3%+33.4%-143.3%at low

AbbVie Working Capital History

DateAnnualQuarterly
Sept 2024
-
-$15.28 B(+88.6%)
June 2024
-
-$8.10 B(+205.5%)
Mar 2024
-
-$2.65 B(-45.2%)
Dec 2023
-$4.84 B(+350.1%)
-$4.84 B(+212.4%)
Sept 2023
-
-$1.55 B(-54.3%)
June 2023
-
-$3.39 B(+207.4%)
Mar 2023
-
-$1.10 B(+2.5%)
Dec 2022
-$1.07 B(-85.2%)
-$1.07 B(-54.2%)
Sept 2022
-
-$2.35 B(-56.3%)
June 2022
-
-$5.37 B(-10.6%)
Mar 2022
-
-$6.01 B(-17.3%)
Dec 2021
-$7.27 B(+61.9%)
-$7.27 B(-1813.7%)
Sept 2021
-
$424.00 M(-115.8%)
June 2021
-
-$2.69 B(-50.1%)
Mar 2021
-
-$5.38 B(+19.9%)
Dec 2020
-$4.49 B(-113.2%)
-$4.49 B(+282.9%)
Sept 2020
-
-$1.17 B(-65.4%)
June 2020
-
-$3.39 B(-109.6%)
Mar 2020
-
$35.29 B(+4.0%)
Dec 2019
$33.93 B(<-9900.0%)
$33.93 B(+1169.5%)
Sept 2019
-
$2.67 B(-245.2%)
June 2019
-
-$1.84 B(-461.7%)
Mar 2019
-
$509.00 M(-273.1%)
Dec 2018
-$294.00 M
-$294.00 M(-109.6%)
Sept 2018
-
$3.08 B(-191.1%)
June 2018
-
-$3.38 B(-199.8%)
DateAnnualQuarterly
Mar 2018
-
$3.39 B(-26.1%)
Dec 2017
$4.58 B(-28.5%)
$4.58 B(-22.3%)
Sept 2017
-
$5.90 B(+25.4%)
June 2017
-
$4.70 B(-29.8%)
Mar 2017
-
$6.70 B(+4.6%)
Dec 2016
$6.41 B(+18.2%)
$6.41 B(-10.9%)
Sept 2016
-
$7.19 B(-4.4%)
June 2016
-
$7.52 B(+26.2%)
Mar 2016
-
$5.96 B(+10.0%)
Dec 2015
$5.42 B(+15.6%)
$5.42 B(-40.4%)
Sept 2015
-
$9.10 B(+61.9%)
June 2015
-
$5.62 B(+28.9%)
Mar 2015
-
$4.36 B(-7.0%)
Dec 2014
$4.69 B(-57.3%)
$4.69 B(-57.1%)
Sept 2014
-
$10.92 B(-4.9%)
June 2014
-
$11.48 B(+3.3%)
Mar 2014
-
$11.11 B(+1.3%)
Dec 2013
$10.97 B(+27.9%)
$10.97 B(+13.5%)
Sept 2013
-
$9.67 B(+9.2%)
June 2013
-
$8.86 B(+8.6%)
Mar 2013
-
$8.16 B(-4.9%)
Dec 2012
$8.58 B(+488.7%)
$8.58 B(+54.2%)
Sept 2012
-
$5.56 B(+382.4%)
June 2012
-
$1.15 B(-6.7%)
Mar 2012
-
$1.24 B(-15.2%)
Dec 2011
$1.46 B(-67.3%)
$1.46 B
Dec 2010
$4.46 B
-

FAQ

  • What is AbbVie annual working capital?
  • What is the all time high annual working capital for AbbVie?
  • What is AbbVie annual working capital year-on-year change?
  • What is AbbVie quarterly working capital?
  • What is the all time high quarterly working capital for AbbVie?
  • What is AbbVie quarterly working capital year-on-year change?

What is AbbVie annual working capital?

The current annual working capital of ABBV is -$4.84 B

What is the all time high annual working capital for AbbVie?

AbbVie all-time high annual working capital is $33.93 B

What is AbbVie annual working capital year-on-year change?

Over the past year, ABBV annual working capital has changed by -$3.76 B (-350.14%)

What is AbbVie quarterly working capital?

The current quarterly working capital of ABBV is -$15.28 B

What is the all time high quarterly working capital for AbbVie?

AbbVie all-time high quarterly working capital is $35.29 B

What is AbbVie quarterly working capital year-on-year change?

Over the past year, ABBV quarterly working capital has changed by -$13.73 B (-886.25%)